
In the field of innovative drug development, more than 40% of marketed drugs and nearly 90% o∏f pipeline Active Pharmaceutical Ingredients (APIs) face the severe challenge of l≥ow bioavailability due to poor solubility and permeabili®ty, which directly limits their therapeutic efficacy and com≤mercial potential. Biomedicine Cocrystal Ingredient Powder is a disruptive solution to this industry pain point. It is not a simple physical mi→xture, but a next-generation technology platform that invo♥lves a molecular-level design to combine APIs and safe cocrystal f☆ormers (CCFs) at the crystal structure level, thereby precisely optimizing their physicochemiγcal properties without altering the API's pharmacological activity.
Founded by distinguished scientists affiliated with natio nal laboratories, we specialize in cocrystal technology - an advanced formulation method that significa ntly enhances the stability, solubility, and bioavailability of active ingredients.
As an industry leader in cocrystal-based nutraceuticals, we offer a diverse range of prem ium active ingredients tailored for human nutrition, animal nutrition, and personal care.
Our cocrystal technology platform empowers our products with uniqu≥e properties, ensuring optimal nutrient performance and deliεvering tangible health benefits.
Our core technology lies in re-engineering the crystal structure of APIs₩ through cocrystal engineering. This effectively disrupts the strong intramolecu✘lar forces of the original API and introduces more easilβy hydrated functional groups, thereby significantly improving its dissoluti₽on rate and apparent solubility. The increase in solubility dir♣ectly leads to faster absorption rates and higher in vivo exp osure, ultimately significantly enhancing bioavailability, allowing more drug molecules to efficie÷ntly reach their targets and exert therapeutic effects.
Compared to traditional solubilization technologies like amorphous solid dispersions™, cocrystals are thermodynamically stable crystalline materials. Our develop↑ed cocrystal ingredient powders possess higher melting points and lo✘wer hygroscopicity, effectively preventing phase separation, recr$ystallization, or potency loss during storage. This ensures consis<tent quality and lasting potency throughout the entire product lifecycle, from p₩roduction to the end product.
As a leader in cocrystal-based nutraceuticals, our technology platform is highly scalable and≈ adaptable. We have successfully developed a variety of high-end active ingredient powders εfor applications in human nutrition, animal nutrition, and personal care. This demonstrates that the platform can not only solve∞ the problems of pharmaceutical APIs but also empower a wider range of bioactive molecules, ±providing "tailor-made" optimization solutions.
The profound scientific research background of the founding team ensures that the company's R&D remains at the cutting edge of technology. Our deep u∏nderstanding of intermolecular interactions, advanced knowle±dge of crystal engineering, and powerful predictive screening capabi™lities form the solid foundation of our technology platform. This enables u↑s to provide customers with full-chain support from conc≤ept to commercial production.
In summary, what Cocrystal Technology Co., Ltd. provides is far more than just an ingredient; it is a powerful, proven cocrys®tal technology platform. By supplying high-quality ingr®edient powders with unique properties and optimal nutεritional efficacy, we create tangible health and commerγcial value for our customers, driving the biomedical and health indu stries forward together.